Pangenome Analysis of <i>Mycobacterium tuberculosis</i> Reveals Core-Drug Targets and Screening of Promising Lead Compounds for Drug Discovery

Tuberculosis, caused by <i>Mycobacterium tuberculosis</i> (<i>M. tuberculosis</i>), is one of the leading causes of human deaths globally according to the WHO TB 2019 report. The continuous rise in multi- and extensive-drug resistance in <i>M. tuberculosis</i> bro...

Full description

Bibliographic Details
Main Authors: Hamza Arshad Dar, Tahreem Zaheer, Nimat Ullah, Syeda Marriam Bakhtiar, Tianyu Zhang, Muhammad Yasir, Esam I. Azhar, Amjad Ali
Format: Article
Language:English
Published: MDPI AG 2020-11-01
Series:Antibiotics
Subjects:
Online Access:https://www.mdpi.com/2079-6382/9/11/819
_version_ 1797547630058799104
author Hamza Arshad Dar
Tahreem Zaheer
Nimat Ullah
Syeda Marriam Bakhtiar
Tianyu Zhang
Muhammad Yasir
Esam I. Azhar
Amjad Ali
author_facet Hamza Arshad Dar
Tahreem Zaheer
Nimat Ullah
Syeda Marriam Bakhtiar
Tianyu Zhang
Muhammad Yasir
Esam I. Azhar
Amjad Ali
author_sort Hamza Arshad Dar
collection DOAJ
description Tuberculosis, caused by <i>Mycobacterium tuberculosis</i> (<i>M. tuberculosis</i>), is one of the leading causes of human deaths globally according to the WHO TB 2019 report. The continuous rise in multi- and extensive-drug resistance in <i>M. tuberculosis</i> broadens the challenges to control tuberculosis. The availability of a large number of completely sequenced genomes of <i>M. tuberculosis</i> has provided an opportunity to explore the pangenome of the species along with the pan-phylogeny and to identify potential novel drug targets leading to drug discovery. We attempt to calculate the pangenome of <i>M. tuberculosis</i> that comprises a total of 150 complete genomes and performed the phylo-genomic classification and analysis. Further, the conserved core genome (1251 proteins) is subjected to various sequential filters (non-human homology, essentiality, virulence, physicochemical parameters, and pathway analysis) resulted in identification of eight putative broad-spectrum drug targets. Upon molecular docking analyses of these targets with ligands available at the DrugBank database shortlisted a total of five promising ligands with projected inhibitory potential; namely, 2′deoxy-thymidine-5′-diphospho-alpha-<span style="font-variant: small-caps;">d</span>-glucose, uridine diphosphate glucose, 2′-deoxy-thymidine-beta-<span style="font-variant: small-caps;">l</span>-rhamnose, thymidine-5′-triphosphate, and citicoline. We are confident that with further lead optimization and experimental validation, these lead compounds may provide a sound basis to develop safe and effective drugs against tuberculosis disease in humans.
first_indexed 2024-03-10T14:46:48Z
format Article
id doaj.art-70a1353983c1424cb62e109c2d4cf798
institution Directory Open Access Journal
issn 2079-6382
language English
last_indexed 2024-03-10T14:46:48Z
publishDate 2020-11-01
publisher MDPI AG
record_format Article
series Antibiotics
spelling doaj.art-70a1353983c1424cb62e109c2d4cf7982023-11-20T21:17:13ZengMDPI AGAntibiotics2079-63822020-11-0191181910.3390/antibiotics9110819Pangenome Analysis of <i>Mycobacterium tuberculosis</i> Reveals Core-Drug Targets and Screening of Promising Lead Compounds for Drug DiscoveryHamza Arshad Dar0Tahreem Zaheer1Nimat Ullah2Syeda Marriam Bakhtiar3Tianyu Zhang4Muhammad Yasir5Esam I. Azhar6Amjad Ali7Atta-ur-Rahman School of Applied Biosciences, National University of Sciences and Technology, Islamabad 44000, PakistanAtta-ur-Rahman School of Applied Biosciences, National University of Sciences and Technology, Islamabad 44000, PakistanAtta-ur-Rahman School of Applied Biosciences, National University of Sciences and Technology, Islamabad 44000, PakistanDepartment of Bioinformatics and Biosciences, Capital University of Science and Technology Islamabad expressway, Kahuta Road, Zone-V, Islamabad 44000, PakistanState Key Laboratory of Respiratory Disease, Guangzhou Institutes of Biomedicine and Health (GIBH), Chinese Academy of Sciences, Guangzhou 510530, ChinaSpecial Infectious Agents Unit, King Fahd Medical Research Center, King Abdulaziz University, Jeddah 21589, Saudi ArabiaSpecial Infectious Agents Unit, King Fahd Medical Research Center, King Abdulaziz University, Jeddah 21589, Saudi ArabiaAtta-ur-Rahman School of Applied Biosciences, National University of Sciences and Technology, Islamabad 44000, PakistanTuberculosis, caused by <i>Mycobacterium tuberculosis</i> (<i>M. tuberculosis</i>), is one of the leading causes of human deaths globally according to the WHO TB 2019 report. The continuous rise in multi- and extensive-drug resistance in <i>M. tuberculosis</i> broadens the challenges to control tuberculosis. The availability of a large number of completely sequenced genomes of <i>M. tuberculosis</i> has provided an opportunity to explore the pangenome of the species along with the pan-phylogeny and to identify potential novel drug targets leading to drug discovery. We attempt to calculate the pangenome of <i>M. tuberculosis</i> that comprises a total of 150 complete genomes and performed the phylo-genomic classification and analysis. Further, the conserved core genome (1251 proteins) is subjected to various sequential filters (non-human homology, essentiality, virulence, physicochemical parameters, and pathway analysis) resulted in identification of eight putative broad-spectrum drug targets. Upon molecular docking analyses of these targets with ligands available at the DrugBank database shortlisted a total of five promising ligands with projected inhibitory potential; namely, 2′deoxy-thymidine-5′-diphospho-alpha-<span style="font-variant: small-caps;">d</span>-glucose, uridine diphosphate glucose, 2′-deoxy-thymidine-beta-<span style="font-variant: small-caps;">l</span>-rhamnose, thymidine-5′-triphosphate, and citicoline. We are confident that with further lead optimization and experimental validation, these lead compounds may provide a sound basis to develop safe and effective drugs against tuberculosis disease in humans.https://www.mdpi.com/2079-6382/9/11/819<i>Mycobacterium tuberculosis</i>pangenomedrug targetsmolecular dockinglead compoundsdrug discovery
spellingShingle Hamza Arshad Dar
Tahreem Zaheer
Nimat Ullah
Syeda Marriam Bakhtiar
Tianyu Zhang
Muhammad Yasir
Esam I. Azhar
Amjad Ali
Pangenome Analysis of <i>Mycobacterium tuberculosis</i> Reveals Core-Drug Targets and Screening of Promising Lead Compounds for Drug Discovery
Antibiotics
<i>Mycobacterium tuberculosis</i>
pangenome
drug targets
molecular docking
lead compounds
drug discovery
title Pangenome Analysis of <i>Mycobacterium tuberculosis</i> Reveals Core-Drug Targets and Screening of Promising Lead Compounds for Drug Discovery
title_full Pangenome Analysis of <i>Mycobacterium tuberculosis</i> Reveals Core-Drug Targets and Screening of Promising Lead Compounds for Drug Discovery
title_fullStr Pangenome Analysis of <i>Mycobacterium tuberculosis</i> Reveals Core-Drug Targets and Screening of Promising Lead Compounds for Drug Discovery
title_full_unstemmed Pangenome Analysis of <i>Mycobacterium tuberculosis</i> Reveals Core-Drug Targets and Screening of Promising Lead Compounds for Drug Discovery
title_short Pangenome Analysis of <i>Mycobacterium tuberculosis</i> Reveals Core-Drug Targets and Screening of Promising Lead Compounds for Drug Discovery
title_sort pangenome analysis of i mycobacterium tuberculosis i reveals core drug targets and screening of promising lead compounds for drug discovery
topic <i>Mycobacterium tuberculosis</i>
pangenome
drug targets
molecular docking
lead compounds
drug discovery
url https://www.mdpi.com/2079-6382/9/11/819
work_keys_str_mv AT hamzaarshaddar pangenomeanalysisofimycobacteriumtuberculosisirevealscoredrugtargetsandscreeningofpromisingleadcompoundsfordrugdiscovery
AT tahreemzaheer pangenomeanalysisofimycobacteriumtuberculosisirevealscoredrugtargetsandscreeningofpromisingleadcompoundsfordrugdiscovery
AT nimatullah pangenomeanalysisofimycobacteriumtuberculosisirevealscoredrugtargetsandscreeningofpromisingleadcompoundsfordrugdiscovery
AT syedamarriambakhtiar pangenomeanalysisofimycobacteriumtuberculosisirevealscoredrugtargetsandscreeningofpromisingleadcompoundsfordrugdiscovery
AT tianyuzhang pangenomeanalysisofimycobacteriumtuberculosisirevealscoredrugtargetsandscreeningofpromisingleadcompoundsfordrugdiscovery
AT muhammadyasir pangenomeanalysisofimycobacteriumtuberculosisirevealscoredrugtargetsandscreeningofpromisingleadcompoundsfordrugdiscovery
AT esamiazhar pangenomeanalysisofimycobacteriumtuberculosisirevealscoredrugtargetsandscreeningofpromisingleadcompoundsfordrugdiscovery
AT amjadali pangenomeanalysisofimycobacteriumtuberculosisirevealscoredrugtargetsandscreeningofpromisingleadcompoundsfordrugdiscovery